Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine. It operates through the following segments: Asia Pacific, EMEA (Europe, Middle East and Africa), and Americas. The Asia Pacific and EMEA segments involves in selling recell devices. The America segment offers recell devices to compassionate use cases at hospitals that is paid by Biomedical Advanced Research and Development Authority. The company was founded on December 21, 1992 and is headquartered in Royston, the United Kingdom.
Company profile
Ticker
AVHHL, AVHHL
Exchange
Website
CEO
Michael S. Perry
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Avita Medical, Ltd.
SEC CIK
IRS number
202578762
AVHHL stock data
Latest ownership filings
No filings